Evidence map›Paper›PMID 20883417›Full record

ReviewNutrition reviews2010

Dietary lignans: physiology and potential for cardiovascular disease risk reduction.

Julia Peterson, Johanna Dwyer, Herman Adlercreutz, Augustin Scalbert, Paul Jacques, Marjorie L McCullough

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Nutrition reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02391779 (Flaxseed Lignan Enriched Complex for Blood Pressure Reduction in Elderly Participants With High Normal Blood Pressure or Stage I Hypertension), which is not on this map. Cited by 115 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 4 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02391779 phase2completednot on this mapstarted 2015, after this paper: background citation

Flaxseed Lignan Enriched Complex for Blood Pressure Reduction in Elderly Participants With High Normal Blood Pressure or Stage I Hypertension

TypeinterventionalSponsorUniversity of SaskatchewanRan2015 to 2017Enrolled100ConditionsHypertensionArmsBeneFlax®, Walking training, Flexibility training, Placebo (Whey Protein), Dash Eating Plan
3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 4 syntheses or guidelines pooled it, 368 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Julia PetersonJean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging and Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachussets, USA.
Johanna Dwyer
Herman Adlercreutz
Augustin Scalbert
Paul Jacques
Marjorie L McCullough
Jean Mayer Human Nutrition Research Center on Aging · USAmerican Cancer Society · USCentre de Recherche en Nutrition Humaine d'Auvergne · FRUnited States Department of Agriculture · USUniversity of Helsinki · FI

Funding

Cardioprotective Effects of Dietary Flavonoids in the Framingham Offspring CohortR21HL087217 · NHLBI · TUFTS UNIVERSITY BOSTON · PI JACQUES, PAUL F · 2008 to 2009
$395k
NHLBI NIH HHS R21 HL087217NHLBI NIH HHS R21HL087217
6 · The paper itself

Abstract

The present review of the literature on lignan physiology and lignan intervention and epidemiological studies was conducted to determine if lignans decrease the risks of cardiovascular disease in Western populations. Five intervention studies using flaxseed lignan supplements indicated beneficial associations with C-reactive protein, and a meta-analysis that included these studies also suggested lignans have a lowering effect on plasma total and low-density lipoprotein cholesterol. Three intervention studies using sesamin supplements indicated possible lipid- and blood pressure-lowering associations. Eleven human observational epidemiological studies examined dietary intakes of lignans in relation to cardiovascular disease risk. Five showed decreased risk with either increasing dietary intakes of lignans or increased levels of serum enterolactone (an enterolignan used as a biomarker of lignan intake), five studies were of borderline significance, and one was null. The associations between lignans and decreased risk of cardiovascular disease are promising, but they are yet not well established, perhaps due to low lignan intakes in habitual Western diets. At the higher doses used in intervention studies, associations were more evident.

Indexed as

Cardiovascular DiseasesEvidence-Based MedicineFlaxHumansLignansRisk AssessmentRisk FactorsLignans

Identifiers

PMID20883417
PMCPMC2951311
OpenAlexW2170357217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.